News
US stocks closed mixed on Monday, but the Nasdaq Composite and S&P 500 managed to notch fresh records. Wall Street began a ...
The company refused the FDA’s request and will continue shipping its therapy, Elevidys, to Duchenne patients who can still ...
U.S. stock indexes inched their way to more records on Monday to kick off a week full of profit updates from big U.S. compan ...
Sarepta says it will continue to ship Elevidys despite FDA requests that it stop shipments of the Duchenne muscular dystrophy ...
Verizon Communications helped lead the way and rose 4%. The telecom giant reported a stronger profit for the latest quarter ...
By Zachary Stieber Contributing Writer Sarepta Therapeutics will not agree to a regulatory request to pause shipments of a ...
Explore more
Sarepta Therapeutics (SRPT) stock is in focus after the US Food and Drug Administration (FDA) asked the company to halt ...
Real-time index price for Nasdaq Composite (NASX), along with buy or sell indicators, analysis, charts, historical performance, news and more ...
WASHINGTON — President Trump’s major domestic policy law will result in nearly 10 million more people going without health ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results